NasdaqCM - Delayed Quote
USD
NeuroSense Therapeutics Ltd. (NRSN)
1.9900
-0.1400
(-6.57%)
At close: October 30 at 4:00:00 PM EDT
Loading chart for NRSN
- Previous Close
2.1300 - Open
2.2000 - Bid 3.1200 x 200
- Ask 5.1700 x 200
- Day's Range
1.9900 - 2.2200 - 52 Week Range
1.9900 - 25.4000 - Volume
20,177 - Avg. Volume
23,148 - Market Cap (intraday)
3.775M - Beta (5Y Monthly) 1.64
- PE Ratio (TTM)
-- - EPS (TTM)
-47.1000 - Earnings Date (est.) --
- Forward Dividend & Yield -- (0.00%)
- 1y Target Est
78.50 - Zacks Rating Bullish
Recent News
View MorePerformance Overview
Trailing total returns as of 10/30/2026, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .
YTD Return
NRSN
87.06%
S&P 500 (^GSPC)
10.73%
1-Year Return
NRSN
90.39%
S&P 500 (^GSPC)
11.11%
3-Year Return
NRSN
77.54%
S&P 500 (^GSPC)
81.91%
5-Year Return
NRSN
97.81%
S&P 500 (^GSPC)
64.59%
Earnings Trends
View MoreAnalyst Insights
View MoreStatistics
View MoreValuation Measures
-
Market Cap
-
Enterprise Value
-
Trailing P/E
-
Forward P/E
-
PEG Ratio (current)
-
Price/Sales (ttm)
-
Price/Book (mrq)
-
Enterprise Value/Revenue
-
Enterprise Value/EBITDA
Financial Highlights
Profitability and Income Statement
-
Profit Margin
0.00%
-
Return on Assets (ttm)
-247.30%
-
Return on Equity (ttm)
-2,174.98%
-
Revenue (ttm)
--
-
Net Income Avi to Common (ttm)
-11.12M
-
Diluted EPS (ttm)
-47.1000
Balance Sheet and Cash Flow
-
Total Cash (mrq)
166k
-
Total Debt/Equity (mrq)
--
-
Levered Free Cash Flow (ttm)
-3.87M
